LIPIDIC CONJUGATES OF LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH)+ AND THYROTROPIN-RELEASING-HORMONE (TRH)+ THAT RELEASE AND PROTECT THE NATIVE HORMONES IN HOMOGENATES OF HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS

被引:51
作者
TOTH, I [1 ]
FLINN, N [1 ]
HILLERY, A [1 ]
GIBBONS, WA [1 ]
ARTURSSON, P [1 ]
机构
[1] UNIV UPPSALA,BIOMEDICUM,S-75123 UPPSALA,SWEDEN
关键词
LIPIDIC AMINO ACID; LIPIDIC PEPTIDE; DRUG DELIVERY; LHRH; TRH; CACO-2 CELL HOMOGENATE; ENZYME DEGRADATION;
D O I
10.1016/0378-5173(94)90108-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The enzymatically labile peptides LHRH and TRH were conjugated to various lipidic peptides. The conjugates and free peptides were incubated with Caco-2 cell homogenates and their respective degradation profiles were studied following incubation. Conjugation to lipidic peptides increased the half-life of LHRH and TRH. The Caco-2 cell homogenates were capable of cleaving the conjugated lipidic peptide, to release the parent LHRH or TRH. The released LHRH or TRH subsequently demonstrated a longer half-life than when present alone in the incubation mixture, suggesting that the cleaved lipidic peptide is capable of inhibiting enzymes.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 19 条
[1]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[2]  
BAKER J, 1991, PEPTIDE PROTEIN DRUG, P359
[3]   PEPTIDES AND THE BLOOD-BRAIN-BARRIER - LIPOPHILICITY AS A PREDICTOR OF PERMEABILITY [J].
BANKS, WA ;
KASTIN, AJ .
BRAIN RESEARCH BULLETIN, 1985, 15 (03) :287-292
[4]   TRH DEGRADATION RATES VARY WIDELY BETWEEN DIFFERENT ANIMAL SPECIES [J].
BREWSTER, D ;
WALTHAM, K .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (06) :619-622
[5]  
CHANTRET I, 1988, CANCER RES, V48, P1936
[6]  
GIBBONS WA, 1990, LIEBIGS ANN CHEM, P1175
[7]   PHARMACOKINETICS OF GONADOTROPIN-RELEASING-HORMONE AND ITS ANALOGS [J].
HANDELSMAN, DJ ;
SWERDLOFF, RS .
ENDOCRINE REVIEWS, 1986, 7 (01) :95-105
[8]  
LEE VHL, 1988, CRIT REV THER DRUG, V5, P69
[9]  
LEHR CM, 1992, DRUG TARGETING DELIV, P92
[10]  
LEPPALUOTO J, 1977, J CLIN ENDOCR METAB, V35, P477